Mycobacterium tuberculosis infection of host cells in space and time

C Bussi, MG Gutierrez - FEMS microbiology reviews, 2019 - academic.oup.com
Tuberculosis (TB) caused by the bacterial pathogen Mycobacterium tuberculosis (Mtb)
remains one of the deadliest infectious diseases with over a billion deaths in the past 200 …

A comprehensive review of autophagy and its various roles in infectious, non-infectious, and lifestyle diseases: current knowledge and prospects for disease …

R Khandia, M Dadar, A Munjal, K Dhama, K Karthik… - Cells, 2019 - mdpi.com
Autophagy (self-eating) is a conserved cellular degradation process that plays important
roles in maintaining homeostasis and preventing nutritional, metabolic, and infection …

Advancing host-directed therapy for tuberculosis

RS Wallis, R Hafner - Nature Reviews Immunology, 2015 - nature.com
Improved treatments are needed for nearly all forms of Mycobacterium tuberculosis infection.
Adjunctive host-directed therapies have the potential to shorten tuberculosis treatment …

Therapeutic targeting of autophagy in disease: biology and pharmacology

Y Cheng, X Ren, WN Hait, JM Yang, Q Ma - Pharmacological reviews, 2013 - Elsevier
Autophagy, a process of self-digestion of the cytoplasm and organelles through which
cellular components are recycled for reuse or energy production, is an evolutionarily …

Autophagy: A new strategy for host-directed therapy of tuberculosis

S Paik, JK Kim, C Chung, EK Jo - Virulence, 2019 - Taylor & Francis
Tuberculosis (TB), which is primarily caused by the major etiologic agent Mycobacterium
tuberculosis (Mtb), remains a serious infectious disease worldwide. Recently, much effort …

Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action

JJ Kim, HM Lee, DM Shin, W Kim, JM Yuk, HS Jin… - Cell host & …, 2012 - cell.com
The current standard of treatment against tuberculosis consists of a cocktail of first-line
drugs, including isoniazid and pyrazinamide. Although these drugs are known to be …

[HTML][HTML] Vitamin D levels and COVID-19 susceptibility: is there any correlation?

K Razdan, K Singh, D Singh - Medicine in drug discovery, 2020 - Elsevier
Abstract Coronavirus disease (COVID-19) is a major pandemic and now a leading cause of
death worldwide. Currently, no drugs/vaccine is available for the treatment of this disease …

A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive …

E Kraig, LA Linehan, H Liang, TQ Romo, Q Liu… - Experimental …, 2018 - Elsevier
Inhibition of the mechanistic target of rapamycin (mTOR) pathway by rapamycin (RAPA), an
FDA-approved immunosuppressive drug used as a clinical therapy to prevent solid organ …

Vitamin D and immune function: autocrine, paracrine or endocrine?

M Hewison - Scandinavian Journal of Clinical and Laboratory …, 2012 - Taylor & Francis
Prominent amongst the non-classical effects of vitamin D is its interaction with the immune
system. Although this has been recognized for many years, it is only through recent studies …

Mycobacterial signaling through toll-like receptors

J Basu, DM Shin, EK Jo - Frontiers in cellular and infection …, 2012 - frontiersin.org
Studies over the past decade have helped to decipher molecular networks dependent on
Toll-like receptor (TLR) signaling, in mycobacteria-infected macrophages. Stimulation of …